Airway microbiota across age and disease spectrum in cystic fibrosis
暂无分享,去创建一个
W. T. Harris | R. Gibson | J. Clancy | J. Harris | S. McColley | F. Accurso | C. Robertson | P. Zeitlin | K. McCoy | R. Ahrens | S. Sagel | Mark J. Stevens | B. Wagner | E. Zemanick | G. Retsch-Bogart | T. Laguna | G. Kurland | J. Chmiel | Kurtis T. Sobush | Edith T. Zemanick
[1] D. Frank,et al. Investigation of sinonasal microbiome spatial organization in chronic rhinosinusitis , 2017, International forum of allergy & rhinology.
[2] C. Robertson,et al. Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis , 2016, PloS one.
[3] L. Raskin,et al. Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples , 2016, PloS one.
[4] Emily A. Knapp,et al. Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis. , 2016, Chest.
[5] J. Harris,et al. Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis , 2016, PloS one.
[6] N. Pace,et al. Microbial aerosol liberation from soiled textiles isolated during routine residuals handling in a modern health care setting , 2015, Microbiome.
[7] Emily S. Charlson,et al. Multicenter Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals. , 2015, American journal of respiratory and critical care medicine.
[8] S. Donaldson,et al. Lung microbiota across age and disease stage in cystic fibrosis , 2015, Scientific Reports.
[9] V. Lucidi,et al. Changes in Cystic Fibrosis Airway Microbial Community Associated with a Severe Decline in Lung Function , 2015, PloS one.
[10] J. Harris,et al. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods. , 2015, Annals of the American Thoracic Society.
[11] M. Rosenfeld,et al. Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. , 2014, Annals of the American Thoracic Society.
[12] T. DeSantis,et al. The Microbial Community of the Cystic Fibrosis Airway Is Disrupted in Early Life , 2014, PloS one.
[13] Elissa Murphy,et al. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. , 2014, American journal of respiratory and critical care medicine.
[14] J. Carlin,et al. Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis. , 2014, The Journal of pediatrics.
[15] Rohan S. Kulkarni,et al. Correction: Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation , 2014, Microbiome.
[16] Barbara A. Bailey,et al. The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography. , 2014, American journal of respiratory and critical care medicine.
[17] Daniel N. Frank,et al. Explicet: graphical user interface software for metadata-driven management, analysis and visualization of microbiome data , 2013, Bioinform..
[18] Rohan S. Kulkarni,et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation , 2013, Microbiome.
[19] J. Petrosino,et al. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. , 2013, Annals of the American Thoracic Society.
[20] Emily S. Charlson,et al. Widespread colonization of the lung by Tropheryma whipplei in HIV infection. , 2013, American journal of respiratory and critical care medicine.
[21] Patrick D Schloss,et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. , 2013, American journal of respiratory and critical care medicine.
[22] J. Harris,et al. Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations , 2013, PloS one.
[23] Leah M. Feazel,et al. Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity , 2013, Science.
[24] H. Weon,et al. Effects of PCR cycle number and DNA polymerase type on the 16S rRNA gene pyrosequencing analysis of bacterial communities , 2012, Journal of Microbiology.
[25] Pelin Yilmaz,et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..
[26] D. Frank,et al. Prevention of Virus-Induced Type 1 Diabetes with Antibiotic Therapy , 2012, The Journal of Immunology.
[27] S. Dowd,et al. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota , 2012, Proceedings of the National Academy of Sciences.
[28] L. Hoffman,et al. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience , 2012, Thorax.
[29] Elmar Pruesse,et al. SINA: Accurate high-throughput multiple sequence alignment of ribosomal RNA genes , 2012, Bioinform..
[30] Susan Murray,et al. Decade-long bacterial community dynamics in cystic fibrosis airways , 2012, Proceedings of the National Academy of Sciences.
[31] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[32] P. Sly,et al. Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] M. Surette,et al. Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome , 2011, PloS one.
[34] J. Carlin,et al. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial. , 2011, JAMA.
[35] Rob Knight,et al. UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..
[36] Patrick D. Schloss,et al. Assessing and Improving Methods Used in Operational Taxonomic Unit-Based Approaches for 16S rRNA Gene Sequence Analysis , 2011, Applied and Environmental Microbiology.
[37] J. Curtis,et al. Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD , 2011, PloS one.
[38] M. Wolfgang,et al. Analysis of the Bacterial Communities Present in Lungs of Patients with Cystic Fibrosis from American and British Centers , 2010, Journal of Clinical Microbiology.
[39] G. Bellon,et al. Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis , 2010, Thorax.
[40] M. Surette,et al. The genus Prevotella in cystic fibrosis airways. , 2010, Anaerobe.
[41] Eoin L. Brodie,et al. Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients , 2010, PloS one.
[42] Lior Pachter,et al. Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.
[43] L. Saiman,et al. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005. , 2009, Chest.
[44] G. Döring,et al. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[45] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.
[46] J. Emerson,et al. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. , 2009, The Journal of pediatrics.
[47] J. Sarles,et al. Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients , 2008, PloS one.
[48] M. Wolfgang,et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.
[49] N. Pace,et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis , 2007, Proceedings of the National Academy of Sciences.
[50] M. Surette,et al. Cystic fibrosis: a polymicrobial infectious disease. , 2006, Future microbiology.
[51] G. Rogers,et al. Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16S Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling , 2004, Journal of Clinical Microbiology.
[52] R. Gibson,et al. Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.
[53] J. Emerson,et al. Defining a pulmonary exacerbation in cystic fibrosis. , 2001, The Journal of pediatrics.
[54] J. Emerson,et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[55] P Green,et al. Base-calling of automated sequencer traces using phred. II. Error probabilities. , 1998, Genome research.
[56] P. Green,et al. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. , 1998, Genome research.
[57] C. Wainwright,et al. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis. , 2013, The Cochrane database of systematic reviews.
[58] Neil Hunter,et al. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. , 2002, Microbiology.